{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:04:19Z","timestamp":1791813859077,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21173"],"award-info":[{"award-number":["21173"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21754"],"award-info":[{"award-number":["21754"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["21755"],"award-info":[{"award-number":["21755"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.clinthera.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T11:27:00Z","timestamp":1723807620000},"page":"689-695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Aspirin and Ticagrelor Versus Aspirin and Clopidogrel or Prasugrel and the Effect on Staphylococcal-associated Infections: A Real-world Study"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9445-2582","authenticated-orcid":false,"given":"Hani","family":"Essa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wern Yew","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizheng Steven","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Anson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3190-1122","authenticated-orcid":false,"given":"Uazman","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2024.07.001_bib0001","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0002-9343(96)80077-5","volume":"101","author":"therapy","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0002","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jcin.2012.03.018","article-title":"Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes","volume":"5","author":"Truffa","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0003","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00018-009-0210-4","article-title":"Platelets in defense against bacterial pathogens","volume":"67","author":"Yeaman","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0004","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1755-5922.2009.00096.x","article-title":"Ticagrelor: the first reversibly binding oral P2Y12 receptor antagonist","volume":"27","author":"Husted","year":"2009","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0005","first-page":"197","article-title":"Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor","volume":"1","author":"Birkeland","year":"2010","journal-title":"J Blood Med"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0006","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/09537104.2013.842965","article-title":"Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study","volume":"25","author":"Storey","year":"2014","journal-title":"Platelets"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0007","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jacbts.2018.05.005","article-title":"Ticagrelor reduces thromboinflammatory markers in patients with pneumonia","volume":"3","author":"Sexton","year":"2018","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0008","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jamacardio.2019.1189","article-title":"Antibacterial activity of ticagrelor in conventional antiplatelet dosages against antibiotic-resistant gram-positive bacteria","volume":"4","author":"Lancellotti","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0009","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0012","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/2048872614554108","article-title":"Dyspnoea management in acute coronary syndrome patients treated with ticagrelor","volume":"4","author":"Parodi","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0013","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ehjcvp\/pvaa099","article-title":"Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infections","volume":"8","author":"Butt","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0014","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ehjcvp\/pvaa065","article-title":"Risk of infections in patients treated with ticagrelor vs. clopidogrel: a systematic review and meta-analysis","volume":"7","author":"Li","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jmii.2019.06.004","article-title":"Ticagrelor: a promising role in preventing multi-organ failure among patients with sepsis due to resistant gram-positive cocci","volume":"52","author":"Jean","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0016","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.cjca.2018.08.024","article-title":"Effect of clopidogrel vs ticagrelor on platelet aggregation and inflammation markers after percutaneous coronary intervention for ST-elevation myocardial infarction","volume":"34","author":"Jiang","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0017","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1096\/fj.201600616R","article-title":"Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism","volume":"30","author":"Mediero","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0018","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2020.06.016","article-title":"Effect of ticagrelor on reducing the risk of gram-positive infections in patients with acute coronary syndrome","volume":"130","author":"Lupu","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0019","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1093\/infdis\/jiab146","article-title":"Ticagrelor Increases platelet-mediated Staphylococcus aureus killing, resulting in clearance of bacteremia","volume":"224","author":"Ulloa","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0011","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejim.2020.10.016","article-title":"Risk of infectious events in acute myocardial infarction patients treated with ticagrelor or clopidogrel","volume":"85","author":"Lee","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.clinthera.2024.07.001_bib0020","article-title":"Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia","volume":"61","author":"Gentry","year":"2023","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824002029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291824002029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T10:23:30Z","timestamp":1726136610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291824002029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0149291824002029"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.07.001","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin and Ticagrelor Versus Aspirin and Clopidogrel or Prasugrel and the Effect on Staphylococcal-associated Infections: A Real-world Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}